AB-003 (Akso Biopharmaceutical)

N/A

Report date: 2022/02/14 17:04:46

Base Information

Drug NameAB-003 (Akso Biopharmaceutical)
Drug Alias NameAB-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed death-ligand 2 inhibitors
TargetsProgrammed death-ligand 1Programmed death-ligand 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkso Biopharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkso Biopharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A